DNAトランスクリプションの調節:ASO治療の未来?
1RNA Therapeutic Institute, UMASS Chan Medical School, Worcester, MA 01581, USA.
Cell
|June 10, 2022
まとめ
研究者らは,脊髄筋縮 (SMA) の薬であるヌシネルセンが,抑制性クロマチンの改変を促進することによって,その効果を阻害することがわかった. この制限を克服し,よりよいSMA治療のためのエクソンインクルージョンを改善することができます.
科学分野:
- 遺伝学 と エピジェネティクス
- 治療薬の開発
- 神経変性疾患
背景:
- 脊髄筋縮 (SMA) は,モーターニューロンに影響する重篤な遺伝疾患です.
- ヌシネルセンなどのアンチセンスオリゴヌクレオチド (ASO) 療法は,SMAの主要な治療法である.
- ヌシナーセンは,SMN2遺伝子へのエクソンのインクルージョンを促す作用がある.
研究 の 目的:
- SMAの治療におけるヌシナーセンの有効性を制限する潜在的なメカニズムを調査する.
- nusinersenの治療効果を高めるための戦略を特定する.
主な方法:
- ヌシナーセン治療によるクロマチンの変化の分析
- エクソン含有に対する抑制性クロマチンの影響の評価
- ヒストン脱酸化剤 (HDAC) 阻害剤とヌシナーセンの併用薬の評価
主要な成果:
- ヌシナーセンの治療は,抑制性クロマチンの変化を誘発することが判明した.
- これらの変更は,エクソンの含有による意図された効果を相殺することが観察されました.
- HDAC阻害剤とNusinersenの併用は,エクソンインクルージョンを成功裏に増強しました.
結論:
- 抑制性クロマチンの変異は,SMAに対するヌシナーセン治療の固有の制限です.
- ヒストン脱酸化酵素阻害剤は,この制限を克服し,ASOの有効性を改善する戦略を提供します.
- この発見は,SMAに対する反意味オリゴヌクレオチドベースの治療法を強化するための新しいアプローチを提供します.
関連する概念動画
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Types of RNA
6.6K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.6K
Transcription Attenuation in Prokaryotes
16.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
16.2K
Regulation of Expression at Multiple Steps
1.1K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.1K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K


